Radiopharm Theranostics Ltd ADR (RADX)

$16.19 +10.59 (189.11%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 10,245
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; a...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3, Carlton, Australia
RadioIsotope25
RadioIsotope25 Apr. 25 at 5:35 PM
$RADX $5 million cash earned coming in July non-dilutive from Australia. They may be signaling openness to strategic interest Not raising right now also keeps the cap table cleaner if: Lantheus Holdings or Novartis start circling post-data. If they raised aggressively today: it could weaken a buyout narrative or signal they expect to go it alone $LNTH $NVS
1 · Reply
StJohn_TudorJones
StJohn_TudorJones Apr. 25 at 1:32 AM
$RADX RAD101 final Ph2b readout as early as May possible — RADX CEO said ‘May/June’ in this webinar (from ~month ago) @RadioIsotope25 thx for sharing this one, hadn’t seen it
1 · Reply
Lalalilala
Lalalilala Apr. 24 at 7:29 PM
$RADX Radiopharm Theranostics announced they will present P1 Non-Small-Cell Lung Cancer|Small Cell Lung Cancer|Melanoma|Head and Neck Cancer|Endometrial Cancer|Breast Cancer results in 3Q26 for RAD-204
1 · Reply
RadioIsotope25
RadioIsotope25 Apr. 24 at 7:21 PM
Moving on up $RADX
0 · Reply
Lalalilala
Lalalilala Apr. 24 at 4:26 PM
$RADX I'm trying to breathe some life into it. 🤣🤣
1 · Reply
Peligroso
Peligroso Apr. 24 at 3:05 PM
$RADX IMO $GEHC will be the ultimate buyer. They recognize the growth potential of PET and are building out their pharmaceutical diagnostics segment. $LNTH is obv another potential buyer but they are a bit low on cash after multiple radiopharma acquisitions last year.
1 · Reply
RadioIsotope25
RadioIsotope25 Apr. 24 at 2:55 PM
$RADX https://youtu.be/wKKedUvNpnI
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 24 at 2:00 PM
$RADX ((data in June)) Strong data (≈90%) ✅ your base case What it means: Clearly better than MRI Clinically meaningful differentiation Opens door to: Acquisition Fast-track Phase 3 Valuation logic: RAD101 = $400–600M asset Add small therapeutic optionality 👉 Market cap: $300–500M 👉 Stock price: $25 – $42 $AKTS $CATX
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 24 at 1:57 PM
$RADX RADX is the only one where success is NOT priced in — and it's the closest to proving it. $AKTS $CATX
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 24 at 1:55 PM
$RADX Mispricing summary Company Expected Value Current Value Mispricing RADX ~$525M ~$60M ~9x undervalued AKTS ~$300M ~$1B ~3x overvalued CATX ~$140M ~$550M ~4x overvalued $AKTS $CATX
0 · Reply
Latest News on RADX
Radiopharm Theranostics Reports Business Update

Thu, 23 Apr 2026 07:00:00 -0400 - 2 days ago

Radiopharm Theranostics Reports Business Update

Radiopharm Theranostics Signs Supply Deal With Siemens Healthineers For RAD101

2026-04-07T12:01:22.000Z - 18 days ago

Radiopharm Theranostics Signs Supply Deal With Siemens Healthineers For RAD101

Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.

Tue, 07 Apr 2026 07:00:00 -0400 - 18 days ago

Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.

Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer

Fri, 27 Mar 2026 07:00:00 -0400 - 4 weeks ago

Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer

Radiopharm Theranostics Eyes Pivotal Trial Path After Encouraging Interim Results

Tue, 24 Mar 2026 10:56:48 -0400 - 4 weeks ago

Radiopharm Theranostics Eyes Pivotal Trial Path After Encouraging Interim Results

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

Wed, 28 Jan 2026 07:00:00 -0500 - 3 months ago

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

RAD Increases Ownership in Radiopharm Ventures to 87.5%

Mon, 12 Jan 2026 07:00:00 -0500 - 3 months ago

RAD Increases Ownership in Radiopharm Ventures to 87.5%

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Mon, 15 Dec 2025 11:59:59 -0500 - 4 months ago

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Mon, 15 Dec 2025 07:00:00 -0500 - 4 months ago

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Radiopharm Theranostics (RADX): Analyst Maintains 'Buy' as Price Target Adjusts | RADX Stock News

2025-11-26T18:34:17.000Z - 5 months ago

Radiopharm Theranostics (RADX): Analyst Maintains 'Buy' as Price Target Adjusts | RADX Stock News

Lantheus (LNTH) Commits to Significant Investment in Radiopharm Theranostics

2025-10-20T13:30:38.000Z - 6 months ago

Lantheus (LNTH) Commits to Significant Investment in Radiopharm Theranostics

Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan

Mon, 20 Oct 2025 07:30:00 -0400 - 6 months ago

Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan

Regal-backed biotech Radiopharm Theranostics launches $35m placement

2025-10-15T23:01:20.000Z - 6 months ago

Regal-backed biotech Radiopharm Theranostics launches $35m placement

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

Tue, 29 Jul 2025 07:30:00 -0400 - 9 months ago

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Tue, 22 Jul 2025 08:00:00 -0400 - 9 months ago

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

Mon, 02 Jun 2025 08:00:00 -0400 - 11 months ago

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

Mon, 19 May 2025 08:00:00 -0400 - 1 year ago

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

2025-03-12T16:57:48.000Z - 1 year ago

This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

Mon, 30 Dec 2024 08:00:00 -0500 - 1 year ago

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Fri, 20 Dec 2024 08:00:00 -0500 - 1 year ago

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

Thu, 19 Sep 2024 12:00:00 -0400 - 1 year ago

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

RadioIsotope25
RadioIsotope25 Apr. 25 at 5:35 PM
$RADX $5 million cash earned coming in July non-dilutive from Australia. They may be signaling openness to strategic interest Not raising right now also keeps the cap table cleaner if: Lantheus Holdings or Novartis start circling post-data. If they raised aggressively today: it could weaken a buyout narrative or signal they expect to go it alone $LNTH $NVS
1 · Reply
StJohn_TudorJones
StJohn_TudorJones Apr. 25 at 1:32 AM
$RADX RAD101 final Ph2b readout as early as May possible — RADX CEO said ‘May/June’ in this webinar (from ~month ago) @RadioIsotope25 thx for sharing this one, hadn’t seen it
1 · Reply
Lalalilala
Lalalilala Apr. 24 at 7:29 PM
$RADX Radiopharm Theranostics announced they will present P1 Non-Small-Cell Lung Cancer|Small Cell Lung Cancer|Melanoma|Head and Neck Cancer|Endometrial Cancer|Breast Cancer results in 3Q26 for RAD-204
1 · Reply
RadioIsotope25
RadioIsotope25 Apr. 24 at 7:21 PM
Moving on up $RADX
0 · Reply
Lalalilala
Lalalilala Apr. 24 at 4:26 PM
$RADX I'm trying to breathe some life into it. 🤣🤣
1 · Reply
Peligroso
Peligroso Apr. 24 at 3:05 PM
$RADX IMO $GEHC will be the ultimate buyer. They recognize the growth potential of PET and are building out their pharmaceutical diagnostics segment. $LNTH is obv another potential buyer but they are a bit low on cash after multiple radiopharma acquisitions last year.
1 · Reply
RadioIsotope25
RadioIsotope25 Apr. 24 at 2:55 PM
$RADX https://youtu.be/wKKedUvNpnI
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 24 at 2:00 PM
$RADX ((data in June)) Strong data (≈90%) ✅ your base case What it means: Clearly better than MRI Clinically meaningful differentiation Opens door to: Acquisition Fast-track Phase 3 Valuation logic: RAD101 = $400–600M asset Add small therapeutic optionality 👉 Market cap: $300–500M 👉 Stock price: $25 – $42 $AKTS $CATX
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 24 at 1:57 PM
$RADX RADX is the only one where success is NOT priced in — and it's the closest to proving it. $AKTS $CATX
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 24 at 1:55 PM
$RADX Mispricing summary Company Expected Value Current Value Mispricing RADX ~$525M ~$60M ~9x undervalued AKTS ~$300M ~$1B ~3x overvalued CATX ~$140M ~$550M ~4x overvalued $AKTS $CATX
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 24 at 1:52 PM
$RADX Probability-adjusted valuation 🔵 RADX RAD101: → 65% × $700M = $455M Therapeutics (combined optionality discounted): → ~10% × $700M = $70M 👉 Total expected value ≈ $525M $CATX $LNTH $PSTV $TLX
0 · Reply
alsworthg
alsworthg Apr. 24 at 12:50 PM
$RADX I don't like when this guy posts
2 · Reply
Lalalilala
Lalalilala Apr. 24 at 11:25 AM
$RADX Today is the day to buy below $4.50. I'm going to place my first order at $4.45, we'll see what happens. $4.45, then $4.31, and $4.21 correspond to three support levels on the daily chart. 830 shares at each level. Have a good day and a good weekend. I'm keeping a few euros in case we happen to fall below $4. 😏 They're going to raise funds, it's inevitable.
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 23 at 9:48 PM
$30 target 🎯 $RADX
0 · Reply
StJohn_TudorJones
StJohn_TudorJones Apr. 23 at 7:52 PM
$RADX as @Lalalilala highlighted, all longs need to read the latest 6-K cash burn part and RADX’s answers on it there
2 · Reply
RadioIsotope25
RadioIsotope25 Apr. 23 at 7:51 PM
Biotech isn’t for the faint of heart. Monopar went to $80 last year. This is coiled with rad101 and rad202. Valuation is low anything can happen. $RADX
0 · Reply
Lalalilala
Lalalilala Apr. 23 at 7:19 PM
$RADX We're at $4.73 and it's selling for $4.60. It's rare to see offers below the current price...
0 · Reply
Lalalilala
Lalalilala Apr. 23 at 7:15 PM
$RADX This confirms that with the slightest rise, we'll be diluted. Perhaps that's one of the reasons why there isn't much buying? 🤔 I don't dare imagine bad results for RAD 101... Good luck. I'll continue buying now that I've partially exited AMD. 5500 more shares to acquire and I'll stop until RAD 101. I hope to see at least $10...
1 · Reply
RadioIsotope25
RadioIsotope25 Apr. 23 at 2:24 PM
$RADX I think we could see some major investors in AKTS buying RADX
0 · Reply
Lalalilala
Lalalilala Apr. 23 at 1:38 PM
$RADX I'm currently buying back 2500 shares and they're trading between $4.57 and $4.65. Good trade! 😉
0 · Reply
alsworthg
alsworthg Apr. 23 at 12:52 PM
$RADX lets see a surge!!!!!!!
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 23 at 12:24 PM
$RADX Rad101 worth $150 million plus cash
0 · Reply